{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:19:12Z","timestamp":1788383952084,"version":"build-2803163510"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T00:00:00Z","timestamp":1502064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spain","award":["AGL2015-65046-C2-1-R"],"award-info":[{"award-number":["AGL2015-65046-C2-1-R"]}]},{"name":"Italian Ministry of Health","award":["GR-2010-2312769"],"award-info":[{"award-number":["GR-2010-2312769"]}]},{"name":"CJD Foundation"},{"name":"E-Rare Joint Transnational Call","award":["CHAPRION, E-Rare-2"],"award-info":[{"award-number":["CHAPRION, E-Rare-2"]}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"crossref","award":["TCP14009"],"award-info":[{"award-number":["TCP14009"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0182589","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T17:30:46Z","timestamp":1502127046000},"page":"e0182589","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein"],"prefix":"10.1371","volume":"12","author":[{"given":"Claudia","family":"Stincardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-2696","authenticated-orcid":true,"given":"Tania","family":"Massignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7294-6765","authenticated-orcid":true,"given":"Silvia","family":"Biggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saioa R.","family":"Elezgarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7649-5562","authenticated-orcid":true,"given":"Valeria","family":"Sangiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-4263","authenticated-orcid":true,"given":"Ilaria","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pancher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-9393","authenticated-orcid":true,"given":"Valentina","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Stravalaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Maietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1014-6225","authenticated-orcid":true,"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-7632","authenticated-orcid":true,"given":"Alessandro","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas R.","family":"Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2216-1361","authenticated-orcid":true,"given":"Joaqu\u00edn","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romolo","family":"Nonno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-6341","authenticated-orcid":true,"given":"Emiliano","family":"Biasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,8,7]]},"reference":[{"key":"ref1","article-title":"Cold Spring Harbor","author":"SB Prusiner","year":"2004"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"SB Prusiner","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5852","key":"ref3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1138718","article-title":"A general model of prion strains and their pathogenicity","volume":"318","author":"J Collinge","year":"2007","journal-title":"Science"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1871526510909010081","article-title":"Recent advances in prion chemotherapeutics","volume":"9","author":"VL Sim","year":"2009","journal-title":"Infect Disord Drug Targets"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/187152612800100161","article-title":"Prion disease: chemotherapeutic strategies","volume":"12","author":"VL Sim","year":"2012","journal-title":"Infect Disord Drug Targets"},{"issue":"17","key":"ref6","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"C Korth","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"ref7","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1128\/JVI.77.15.8462-8469.2003","article-title":"Evaluation of quinacrine treatment for prion diseases","volume":"77","author":"A Barret","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/JVI.78.10.4999-5006.2004","article-title":"Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models","volume":"78","author":"K Doh-ura","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000076350","article-title":"Results of quinacrine administration to patients with Creutzfeldt-Jakob disease","volume":"17","author":"M Nakajima","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1440-1789.2009.01058.x","article-title":"Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases","volume":"29","author":"Y Tsuboi","year":"2009","journal-title":"Neuropathology"},{"issue":"5","key":"ref11","first-page":"470","article-title":"Pentosan polysulfate as a prophylactic and therapeutic agent against prion disease","volume":"6","author":"S Dealler","year":"2003","journal-title":"IDrugs"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/JVI.68.4.2135-2141.1994","article-title":"Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]","volume":"68","author":"B Caughey","year":"1994","journal-title":"J Virol"},{"issue":"Pt 3","key":"ref13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1099\/0022-1317-73-3-661","article-title":"Sulphate polyanions prolong the incubation period of scrapie-infected hamsters","volume":"73","author":"A Ladogana","year":"1992","journal-title":"J Gen Virol"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"S Haik","year":"2014","journal-title":"Lancet Neurol"},{"issue":"16","key":"ref15","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"G Forloni","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024430","article-title":"Insights from Therapeutic Studies for PrP Prion Disease","volume":"7","author":"K Teruya","year":"2017","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(05)70225-8","article-title":"Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease","volume":"4","author":"M Polymenidou","year":"2005","journal-title":"Lancet Neurol"},{"key":"ref18","article-title":"Developing Therapeutics for PrP Prion Diseases","author":"K Giles","year":"2017","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"5967","key":"ref19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.1183218","article-title":"Darwinian evolution of prions in cell culture","volume":"327","author":"J Li","year":"2010","journal-title":"Science"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"13148","DOI":"10.1073\/pnas.93.23.13148","article-title":"Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system","volume":"93","author":"S Brandner","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5646","key":"ref21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","article-title":"Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis","volume":"302","author":"G Mallucci","year":"2003","journal-title":"Science"},{"issue":"13","key":"ref22","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4155\/fmc.12.114","article-title":"Targeting the cellular prion protein to treat neurodegeneration","volume":"4","author":"E Biasini","year":"2012","journal-title":"Future medicinal chemistry"},{"key":"ref23","article-title":"Decoding the Function of the N-Terminal Tail of the Cellular Prion Protein to Inspire Novel Therapeutic Avenues for Neurodegenerative Diseases","author":"N Iraci","year":"2014","journal-title":"Virus Res"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1515\/hsz-2016-0190","article-title":"Common therapeutic strategies for prion and Alzheimer's diseases","volume":"397","author":"SR Elezgarai","year":"2016","journal-title":"Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"23180","DOI":"10.1038\/srep23180","article-title":"A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein","volume":"6","author":"T Massignan","year":"2016","journal-title":"Sci Rep"},{"issue":"29","key":"ref26","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.0802759105","article-title":"Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease","volume":"105","author":"MD White","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"50","key":"ref27","doi-asserted-by":"crossref","first-page":"30221","DOI":"10.1074\/jbc.270.50.30221","article-title":"Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells","volume":"270","author":"SL Shyng","year":"1995","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"30221","DOI":"10.1074\/jbc.270.50.30221","article-title":"Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells","volume":"270","author":"S-L Shyng","year":"1995","journal-title":"J Biol Chem"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.wnf.0000134853.36429.0e","article-title":"Combined quinacrine and chlorpromazine therapy in fatal familial insomnia","volume":"27","author":"J Benito-Leon","year":"2004","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.str.2013.11.009","article-title":"Structural basis of prion inhibition by phenothiazine compounds","volume":"22","author":"PK Baral","year":"2014","journal-title":"Structure"},{"issue":"6839","key":"ref31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","article-title":"Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding","volume":"411","author":"GP Saborio","year":"2001","journal-title":"Nature"},{"issue":"46","key":"ref32","doi-asserted-by":"crossref","first-page":"35245","DOI":"10.1074\/jbc.M603964200","article-title":"Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification","volume":"281","author":"P Saa","year":"2006","journal-title":"J Biol Chem"},{"issue":"Pt 12","key":"ref33","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1099\/vir.0.2008\/005520-0","article-title":"The bank vole (Myodes glareolus) as a sensitive bioassay for sheep scrapie","volume":"89","author":"MA Di Bari","year":"2008","journal-title":"J Gen Virol"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"e33472","DOI":"10.1371\/journal.pone.0033472","article-title":"The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cells","volume":"7","author":"E Biasini","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1523\/JNEUROSCI.3406-12.2013","article-title":"A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity","volume":"33","author":"E Biasini","year":"2013","journal-title":"J Neurosci"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4161\/pri.6.1.18627","article-title":"Ion channels induced by the prion protein: mediators of neurotoxicity","volume":"6","author":"IH Solomon","year":"2012","journal-title":"Prion"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ymeth.2010.11.005","article-title":"A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guide","volume":"53","author":"T Massignan","year":"2011","journal-title":"Methods"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1074\/jbc.M109.064949","article-title":"A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein","volume":"285","author":"T Massignan","year":"2010","journal-title":"J Biol Chem"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/tra.12272","article-title":"Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis","volume":"16","author":"JA Daniel","year":"2015","journal-title":"Traffic"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1074\/jbc.M110.168468","article-title":"The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71","volume":"286","author":"KM Hussain","year":"2011","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/bmb\/66.1.71","article-title":"Trafficking, turnover and membrane topology of PrP","volume":"66","author":"DA Harris","year":"2003","journal-title":"Br Med Bull"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"e5829","DOI":"10.1371\/journal.pone.0005829","article-title":"Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells","volume":"4","author":"D Sarnataro","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1083\/jcb.125.6.1239","article-title":"A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits","volume":"125","author":"SL Shyng","year":"1994","journal-title":"J Cell Biol"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20100615","article-title":"The hydrophobic core region governs mutant prion protein aggregation and intracellular retention","volume":"430","author":"E Biasini","year":"2010","journal-title":"Biochem J"},{"issue":"4","key":"ref45","first-page":"321","article-title":"Influence of aminasine on experimental scrapie in mice","volume":"28","author":"VM Roikhel","year":"1984","journal-title":"Acta Virol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.schres.2005.01.003","article-title":"From dopamine to salience to psychosis\u2014linking biology, pharmacology and phenomenology of psychosis","volume":"79","author":"S Kapur","year":"2005","journal-title":"Schizophr Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-59745-178-9_2","article-title":"Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?","volume":"440","author":"AI Ivanov","year":"2008","journal-title":"Methods in molecular biology (Clifton, NJ"},{"issue":"Pt 12","key":"ref48","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1242\/jcs.107.12.3461","article-title":"Rapid endocytosis of interleukin 2 receptors when clathrin-coated pit endocytosis is inhibited","volume":"107","author":"A Subtil","year":"1994","journal-title":"J Cell Sci"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ncb2473","article-title":"Distinct and separable activities of the endocytic clathrin-coat components Fcho1\/2 and AP-2 in developmental patterning","volume":"14","author":"PK Umasankar","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","article-title":"Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation","volume":"123","author":"LH Wang","year":"1993","journal-title":"J Cell Biol"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"e106516","DOI":"10.1371\/journal.pone.0106516","article-title":"Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells","volume":"9","author":"T Yamasaki","year":"2014","journal-title":"PLoS One"},{"issue":"16","key":"ref52","doi-asserted-by":"crossref","first-page":"14724","DOI":"10.1074\/jbc.M110.214973","article-title":"An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity","volume":"286","author":"IH Solomon","year":"2011","journal-title":"J Biol Chem"},{"issue":"Pt 22","key":"ref53","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1242\/jcs.046292","article-title":"Clathrin-independent internalization of normal cellular prion protein in neuroblastoma cells is associated with the Arf6 pathway","volume":"122","author":"YS Kang","year":"2009","journal-title":"J Cell Sci"},{"issue":"Pt 5","key":"ref54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1042\/BST0371022","article-title":"Dissecting dynamin's role in clathrin-mediated endocytosis","volume":"37","author":"M Mettlen","year":"2009","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"ref55","first-page":"15","article-title":"Proteolytic processing of the prion protein in health and disease","volume":"1","author":"HC Altmeppen","year":"2012","journal-title":"American journal of neurodegenerative disease"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1471-4159.2006.04439.x","article-title":"Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation","volume":"101","author":"I Filesi","year":"2007","journal-title":"J Neurochem"},{"issue":"9","key":"ref57","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/JVI.02412-08","article-title":"Cells expressing anchorless prion protein are resistant to scrapie infection","volume":"83","author":"KL McNally","year":"2009","journal-title":"J Virol"},{"issue":"11","key":"ref58","doi-asserted-by":"crossref","first-page":"e7816","DOI":"10.1371\/journal.pone.0007816","article-title":"Immunopurification of pathological prion protein aggregates","volume":"4","author":"E Biasini","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2353\/ajpath.2010.091007","article-title":"A highly toxic cellular prion protein induces a novel, nonapoptotic form of neuronal death","volume":"176","author":"HM Christensen","year":"2010","journal-title":"Am J Pathol"},{"issue":"45","key":"ref60","doi-asserted-by":"crossref","first-page":"42409","DOI":"10.1074\/jbc.M106928200","article-title":"Mutant prion proteins are partially retained in the endoplasmic reticulum","volume":"276","author":"L Ivanova","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20130563","article-title":"Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases","volume":"454","author":"L Tapella","year":"2013","journal-title":"Biochem J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0182589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T21:21:00Z","timestamp":1659302460000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0182589"}},"subtitle":[],"editor":[{"given":"Ina Maja","family":"Vorberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,7]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0182589","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,7]]}}}